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Klebsiella pneumoniae isolates frequently contain complex mixtures of blaSHV alleles. A high-resolution
melting-based method for interrogating the extended-spectrum activity conferring codon 238 and 240 poly-
morphisms was developed. This detects minority extended-spectrum -lactamase-encoding alleles, allows
estimation of allele ratios, and discriminates between single and double mutants.
High-resolution melting (HRM) analysis is showing consid-
erable promise as a method for rapid and cost-effective inter-
rogation of single nucleotide polymorphisms (SNPs) (5). There
have been numerous reports of the successful use of HRM to
discriminate homozygotes and heterozygotes in humans (5).
However, the use of HRM to analyze allele mixtures that are
not 1:1 and to reveal the presence of minority alleles has been
little explored.
The increasing prevalence of bacteria producing extended-
spectrum -lactamases (ESBLs) has become a significant prob-
lem facing health care across the world. Many ESBLs are
derived from plasmid-encoded SHV or TEM -lactamases
(12–14). The conversion of a non-ESBL SHV enzyme into an
ESBL is nearly always associated with a G238S (GGC3AGC)
substitution (numbering according to that of Ambler et al. [1]),
while a further extension of the spectrum of activity is medi-
ated by an E240K (GAG3AAG) substitution (12). Although
there are many other substitutions reported, mutations of
codons 238 and 240 are by far the most significant for ESBL
activity of the blaSHV family (http://www.lahey.org/Studies/).
An unusual aspect of the biology of the SHV-encoding gene,
blaSHV, is that it is present on the chromosome of most Klebsiella
pneumoniae strains (2, 3). However, it is also disseminated on
plasmids, and most SHV ESBLs are plasmid encoded. It appears
that there have been two recent mobilizations of non-ESBL
blaSHV from the K. pneumoniae chromosome onto plasmids, the
mobilized genes being blaSHV-1 and blaSHV-11, which differ only at
codon 35 (7). The G238S mutant-encoding derivatives of these
are blaSHV-2 and blaSHV-2a, respectively, while the G238S and
E240K double-mutant-encoding derivatives are blaSHV-5 and
blaSHV-12, respectively. These six blaSHV variants are all abundant.
The existence of both chromosome and plasmid-borne
blaSHV means that many K. pneumoniae strains harbor mix-
tures of blaSHV alleles, and the ratios between alleles can vary
widely (6, 8, 9). It has also been determined that the presence
of a minority ESBL-encoding allele confers an ESBL-positive
phenotype (9). This provides a diagnostic challenge.
An allele-specific real-time PCR (sometimes known as ki-
netic PCR) method for interrogating the blaSHV codon 238 and
240 SNPs has previously been reported (8, 9). This has proven
effective, but it requires four separate PCRs. Also, it is difficult
to calibrate for interlab comparison because of the effects of
small batch-to-batch variations in primer concentration and
quality (unpublished data). In contrast, the allele discrimina-
tion in an HRM-based assay takes place at the end of the PCR,
so the format is inherently more robust.
Here, we demonstrate a single-tube HRM-based assay for
codon 238 and 240 mutations in the blaSHV gene and its com-
parison with allele-specific real-time PCR. To support this
assay, data analysis methods were developed for the inference
of confidence limits regarding whether or not an analyte con-
tains a mutant allele. This procedure is similar in some respects
to the probe-based melting analyses of Chia et al. and Randeg-
ger and Hachler (4, 15), but it is inherently simpler and pro-
vides more information.
Two isolate collections of K. pneumoniae were used in this
study (Table 1). Isolates A1 to L1 are clinical isolates from the
Princess Alexandra Hospital (PAH) in Brisbane, Australia,
have previously been characterized, and contain various mix-
tures of blaSHV-11, blaSHV-2a, and blaSHV-12 (8, 9, 11, 16). Iso-
lates 14 to 121 are derived from the SENTRY collection (10).
All strains were cultured in Luria-Bertani (LB) broth and
stored in cryovials with 12% glycerol at 80°C. The isolates
that are asterisked in Table 1 are derivatives of the clinical
isolates that have been subjected to selection for resistance to
128 g/ml cefotaxime (8).
DNA was extracted, using a DNeasy tissue kit (Qiagen),
from 2.5-ml cultures grown overnight in LB broth. The resus-
pended DNA was stored at 20°C. All reactions for both the
allele-specific real-time PCR assay and HRM assay were per-
formed in a Rotor-Gene 6000 real-time PCR device (Qiagen).
Allele-specific PCR was carried out essentially as previously
described by Hammond et al. (9). The reactions were per-
formed in 10-l volumes, containing SensiMix NoRef master
mix at a 1 concentration (Quantace), Sybr green I at a 1
concentration, 5 pmol of common primer (Shv238reverse [5-
CGGCGTATCCCGCAGATAA-3] or Shv240reverse [5-CC
GGCGGGCTGGTTTAT-3]), 5pmol of either the wild-type
(WT)-specific primer (Shv238wt [5-CGCCGATAAGACCG
GAGCTG-3] or Shv240wt [5-GCGCGCACCCCGCTC-3])
or mutant-specific primer (Shv238mt [5-CGCCGATAAGAC
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CGGAGCTA-3] or Shv240mt [5-GCGCGCACCCCGCTT-
3]), and 50 ng of DNA template. Thermocycling parameters
were as described by Hammond et al. (9). The CT values were
calculated by subtracting the CT for the WT-specific reaction
from the CT for the mutant-specific reaction. It has previously
been shown by Hammond and coworkers that ESBL-negative
isolates have codon 238 CT values of 2.5 and codon 240
CT values of 5 (8), and these are the cutoffs used for
presumptive mutant allele detection by allele-specific real-
time PCR.
The HRM assay was carried out using primers SHVmutHRM_F
(5-CGCCGATAAGACCGGAGCT-3) and SHVmutHRM_
R (5-CCGCGCGCACCCCGCT-3). These were designed to
anneal very close to the SNPs, and the amplified fragment was
only 39 bp. The small size of this fragment maximizes the
differences in melting temperature (Tm) conferred by the SNPs
and allows for short cycling times. PCR was performed in a
10-l reaction, containing SensiMix NoRef master mix at a 1
concentration (Quantace), Sybr green I at 1 concentration, 5
pmol of each primer, Q-solution at a 1 concentration
(Qiagen), and 1 ng of DNA template. Thermocycling param-
eters were as follows: 50°C for 2 min; 95°C for 10 min; 40 cycles
of 95°C for 5 s, 65°C for 5 s, and 72°C for 10 s; 95°C for 2 min;
and 50°C for 30s. The amplification was followed by HRM
from 70 to 86°C at 0.05°C increments, remaining at each step
for 2 s. In order to calculate confidence limits for conclusions
regarding the sequence of the amplified fragment, the numer-
ical data defining the normalized HRM curves were exported
using the “export” function of the software supplied with the
Corbett 6000 device, and the mean and standard deviation
(SD) were defined at each temperature of the melting proto-
col. From this, the 95% confidence limits were calculated as
TABLE 1. blaSHV allele distributions and results from allele-specific real-time PCR and HRM assays
Origin and
isolate
ESBL
phenotype
% blaSHV alleles Kinetic PCRCTb
WT or single- or
double-mutant strain
Difference in graph
amplitudeWT 238mutation
240
mutation Codon 238 Codon 240 Combined
PAH
B2 Negative 100 0 0 4.97 10.07 15.04 WTc 3.27
K2 Negative 100 0 0 5.38 5.86 11.24 WTc 2.52
J3 Negative 100 0 0 5.22 7.02 12.24 WTc 1.97
A1 Positive 50 50 0 0.32 6.60 6.28 Singlec 10.79
D1 Positive 25 75 10 1.19 6.26 5.07 Singlec 12.96
J2 Positive 80 20 20 1.07 1.36 2.43 Doublec 10.29
L1 Positive 60 40 35 0.27 0.11 0.38 Doublec 17.40
I1 Positive 10 90 65 1.85 3.01 4.86 Doublec 25.91
B1 Positive 1.10 6.71 5.61 Singled 12.07
F1 Positive 1.18 7.36 6.18 Singled 12.19
B1a Positive 1.94 6.98 5.04 Singled 16.16
F1a Positive 1.92 7.93 5.01 Singled 14.92
SENTRY
30 Negative 5.39 6.35 11.74 WTd 1.10
54 Negative 4.91 5.96 10.87 WTd 0.13
70 Negative 5.24 6.18 11.42 WTd 0.24
85 Negative 3.73 9.68 13.41 WTd 1.03
102 Negative 4.71 11.00 15.71 WTd 0.13
104 Negative 4.13 7.35 11.48 WTd 1.46
105 Negative 4.10 7.43 11.53 WTd 1.01
106 Negative 3.90 11.80 15.70 WTd 0.40
107 Negative 3.45 10.65 14.10 WTd 0.11
108 Negative 3.40 7.75 11.15 WTd 2.19
109 Negative 3.69 10.23 13.92 WTd 0.95
110 Negative 4.91 7.04 11.95 WTd 0.24
113 Negative 4.17 12.72 16.89 WTd 0.73
114 Negative 3.92 12.79 16.71 WTd 1.87
115 Negative 3.35 10.93 14.28 WTd 2.23
116 Negative 4.88 12.79 17.67 WTd 1.44
120 Negative 4.67 7.07 11.74 WTd 0.22
121 Negative 5.30 6.82 11.58 WTd 0.51
14 Positive 0.74 0.24 0.98 Doubled 15.28
18 Positive 0.92 4.50 5.42 Doubled 24.88
58 Positive 0.51 4.83 5.34 Singled 16.40
54a Positive 0.16 6.77 6.93 Singled 9.02
110a Positive 1.85 7.61 5.76 Singled 13.13
120a Positive 1.98 7.00 8.98 Singled 4.86
121a Positive 2.06 6.89 8.95 Singled 4.34
a Isolates that were subjected to stepwise selection for resistance to increasing cefotaxime concentrations and are resistant to 128 g/ml cefotaxime.
b Shown are the mean CT measurements from three separate experiments.
c Allele content was directly demonstrated by analysis of cloned PCR products.
d Allele content was deduced on the basis of consistency between the allele-specific real-time PCR, HRM data, and ESBL phenotype.
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FIG. 1. HRM data. (A) Normalized HRM graphs from the PAH isolates. Isolates containing mutated alleles (A1, D1, J2, L1, and I1) are
clearly separated from isolates containing only WT alleles (B2, J3, and K2). (B) Difference graph from the PAH isolates, with the
fluorescence of isolate J3 set as the baseline. For each isolate, the number and allelic distribution are stated. (C) Difference graph of the
additional 27 SENTRY isolates (18 WT, 7 single mutant, 2 double mutant) isolates. The baseline used was the average fluorescence data
of 21 WT (ESBL negative) isolates. The area representing the 95% confidence limit for the WT sequence is delineated with dotted lines.
All ESBL-positive isolates yielded difference graph curves outside the 95% confidence limit area. The two curves with nadirs displaced to
the left are the two double-mutant isolates, 14 and 18.
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the mean 	 1.96  SD. These numbers were used to define a
95% confidence limit area on the difference graph that is
obtained by setting the mean of all of the WT HRM data as the
baseline. The amplitudes at the nadirs of the HRM difference
graphs were calculated with reference to the mean for all WT
isolates.
The fully characterized samples for the development of this
assay were K. pneumoniae clinical isolates with blaSHV allele
ratios that had previously been determined by allele-specific
real-time PCR and also by the cloning and analysis of PCR
products (5, 10). These were subjected to HRM analysis, and
in addition, the allele-specific real-time PCR assays were re-
peated so as to control for the effect on primer extension
efficiency of different primer batches (Table 1 and Fig. 1A and
B). The ESBL-positive isolates were clearly discriminated from
the ESBL-negative isolates, with the mutant samples having
lower Tm values, consistent with the G3A substitutions. The
ESBL-positive isolates included J2, which has 80% WT alleles
and 20% double-mutant (blaSHV-12) alleles. This yielded a very
different HRM curve from the WT isolates. Therefore, this
method can detect mutant alleles when they in the minority.
The clear identification of a minority allele probably reflects
the formation of heteroduplexes which depress the Tm. In the
difference graph (Fig. 1B), it can be seen that the double-
mutant (blaSHV-12)-containing isolates J2, L1, and I1 can be
easily discriminated by eye because the curve nadirs are dis-
placed to the left. However, isolate D1, which contains just
10% double-mutant (blaSHV-12) alleles and a high proportion
of single-mutant (blaSHV-2a) alleles, was not discriminated
from A1, in which only the WT and single-mutant alleles have
been detected. In addition, there was correlation between the
difference graph amplitudes and the ratio between the WT and
mutant alleles. Because the difference graph amplitudes are
derived from melt curves that are always normalized to the
same number of arbitrary fluorescence units by the Corbett
6000 software, they can be compared between runs.
To further test this method, 27 diverse K. pneumoniae iso-
lates (18 WT, 7 single mutants, and 2 double mutants), from
the Asia-Pacific component of the SENTRY program (10)
were subject to analysis. All were analyzed by HRM and allele-
specific real-time PCR (Table 1 and Fig. 1C). Some of these
isolates had been subjected to allele-specific real-time PCR
previously (8, 9), but all isolates were subjected to this proce-
dure during the course of this study. Once again, the ESBL-
positive isolates were discriminated from the ESBL-negative
isolates, and isolates with two mutations were discriminated
from those with one mutation on the basis of displacement of
the nadir of the difference graph to the left. The greater num-
ber of samples enabled the power of the HRM assay to indi-
cate allele ratios to be examined more rigorously. The corre-
lation coefficient for the linear regression of the combined
kinetic PCR CT values versus the amplitude at the nadirs of
the HRM difference graphs for the “single-mutant” ESBL-
positive isolates is 0.94 (P 
 0.0001). The value for “double-
mutant” isolates is 0.98 (P  0.0023). This confirms that this
assay can provide an indication of allele ratios. The data from
the 18 SENTRY WT isolates together with the 3 PAH WT
isolates (B2, J3, and K2) were used to obtain 95% confidence
limits for the HRM curve corresponding to the WT allele. This
not only indicates when the presence of a mutation should be
called but also facilitates the portability of this method. The Tm
of the WT sequence using our Rotor-Gene 6000 device is
79.00 	 0.15°C. It is our experience that an individual Corbett
6000 device is highly accurate with respect to relative temper-
atures during runs, but absolute temperature calibration be-
tween different Corbett 6000 devices can differ by up to 0.5°C.
The 95% confidence limit curves for the WT sequence can
easily be adjusted with reference to a Tm determined from a
small number of runs of the procedure against a WT sequence
on a particular machine.
In conclusion, an HRM-based method for interrogating the
clinically significant codon 238 and codon 240 SNPs of the
blaSHV gene has been developed. The method requires no
probes, makes use of a low-cost Sybr green-based master mix,
detects mutant alleles if they are in the minority, and provides
an indication of the allele ratio. The method costs 
$0.60 per
sample in materials, even when carried out in duplicate, and
takes approximately 1 h.
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